Target intelligence / Profile preview

Plasmodium falciparum G-quadruplex DNA (PfG4)

Target
PfG4
Molecular classification
Nucleic acid, Non-canonical DNA structure
01

Overview

Plasmodium falciparum G-quadruplex (PfG4) DNA sequences are non-canonical secondary structures formed by guanine-rich regions within the genome of the primary malaria-causing parasite (Harris et al., 2018, Nucleic Acids Research). These structures consist of stacked G-tetrads stabilized by Hoogsteen hydrogen bonding and monovalent cations. In P. falciparum, G4s are significantly enriched in key regulatory regions, including telomeres and the promoter regions of var genes, which are responsible for antigenic variation and immune evasion (Marsico et al., 2019, Scientific Reports). By acting as physical barriers or regulatory nodes, PfG4s influence essential processes such as DNA replication, transcription, and telomere stability (Calvo & Wasserman, 2016, Memórias do Instituto Oswaldo Cruz). Targeting these structures with small-molecule ligands, known as G4 stabilizers, offers a novel therapeutic strategy to disrupt the parasite's life cycle and overcome drug resistance (Belmonte-Reche et al., 2016, Future Medicinal Chemistry). Such ligands can inhibit telomerase activity or cause genomic instability by blocking polymerase progression, leading to potent anti-plasmodial effects. Consequently, PfG4s represent a promising target for developing next-generation antimalarial drugs that may bypass existing resistance mechanisms.

Other names
Plasmodium falciparum G4 DNAP. falciparum G-quadruplexesG-quadruplex DNA sequences in Plasmodium falciparumPfG4-DNA
02

Mechanism of action

Stabilization of G-quadruplex structures to inhibit DNA replication, transcription, and telomere maintenance, thereby inducing parasite cell death.

03

Biological functions

Gene expression regulationTelomere maintenanceDNA replication regulationTranscription regulationAntigenic variationImmune evasion
04

Disease associations

InfectionMalaria
05

Safety considerations

Selectivity over human G-quadruplex sequencesPotential systemic toxicity of DNA-binding agentsOff-target effects on host gene regulation
06

Interacting drugs

TMPyP4

6 more in the full profile.

07

Biomarkers

Parasitemia levelsG4-ligand binding affinityvar gene expression levels

Beyond the preview

Go deeper on Plasmodium falciparum G-quadruplex DNA (PfG4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium falciparum G-quadruplex DNA (PfG4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call